Core Laboratories Inc. $CLB Shares Sold by Earnest Partners LLC

Earnest Partners LLC decreased its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 4.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,427,659 shares of the oil and gas company’s stock after selling 175,370 shares during the period. Earnest Partners LLC owned about 7.36% of Core Laboratories worth $42,366,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of CLB. Ariel Investments LLC boosted its holdings in shares of Core Laboratories by 25.5% in the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company’s stock valued at $149,489,000 after buying an additional 2,634,438 shares during the period. Disciplined Growth Investors Inc. MN raised its position in shares of Core Laboratories by 9.7% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock worth $73,787,000 after purchasing an additional 528,976 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Core Laboratories by 3.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,114,560 shares of the oil and gas company’s stock worth $12,842,000 after purchasing an additional 32,934 shares during the last quarter. Gendell Jeffrey L boosted its position in Core Laboratories by 24.6% during the 2nd quarter. Gendell Jeffrey L now owns 569,471 shares of the oil and gas company’s stock valued at $6,560,000 after purchasing an additional 112,475 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC grew its stake in Core Laboratories by 22.2% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 559,625 shares of the oil and gas company’s stock worth $6,917,000 after buying an additional 101,755 shares during the last quarter. 97.81% of the stock is owned by institutional investors and hedge funds.

Core Laboratories Stock Down 0.9%

CLB stock opened at $15.76 on Monday. The firm’s 50-day moving average is $18.32 and its two-hundred day moving average is $15.69. The company has a market capitalization of $733.93 million, a price-to-earnings ratio of 23.53, a price-to-earnings-growth ratio of 13.76 and a beta of 1.10. Core Laboratories Inc. has a 52 week low of $9.72 and a 52 week high of $20.36. The company has a current ratio of 2.07, a quick ratio of 1.57 and a debt-to-equity ratio of 0.39.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business had revenue of $138.26 million during the quarter, compared to analysts’ expectations of $130.40 million. During the same period last year, the firm posted $0.22 earnings per share. The business’s revenue was up 7.0% on a year-over-year basis. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 9th. Shareholders of record on Monday, February 16th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories’s dividend payout ratio (DPR) is presently 5.97%.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.